Israel Active

Nearly 3 million Israelis have now received at least the first dose of the COVID-19 vaccine and nearly 1.7 million have now received the second.  Covid infections and serious illnesses of Israelis over the age of 60 are now 60% lower than before vaccinating started. An inspiring video.

Israel’s Omnix Medical (reported previously) has been awarded €10.8 million in EU funding under the EIC Accelerator Programme, part of the EU’s Horizon 2020 research funding program. Omnix’s OMN6 peptide destroys the bacteria’s membrane, regardless of its resistance.

Israel’s Digestix Bioscience is in the early stage of developing a medical device and treatment to prevent recurrence of certain colorectal polyps. These polyps occur in at least 25% of people over 50 and if not removed can develop into colon cancer.

Israel’s Sofwave (reported previously) has received Europe’s CE Mark plus Israeli approval for its revolutionary skin tightening and wrinkle reduction device. Sofware’s SUPERB (Synchronous Ultrasound Parallel Beam) has already received US FDA approval. https://www.prnewswire.com/news-releases/sofwave-receives-ce-medical-mark-and-additional-key-regulatory-clearances-for-its-revolutionary-skin-tightening-and-wrinkle-reduction-device-301173649.html

Tel Aviv, known for its vegan scene and vibrant culture, was ranked the 6th healthiest city in the world, according to a new report from UK’s Money.co.uk. It compared life expectancy, obesity levels, pollution levels, safety score, sunlight hours, and cost to be healthy.

Israel’s Embrionics is using Artificial Intelligence (AI) to improve the success rates of fertility treatments. Founded by Haredi female entrepreneur Dr.Yael Gold-Zamir, Embrionics is breaking new ground in embryo selection, genetic analysis and utilizing Big Data to help bring happiness to childless couples.

Israel’s Serreno (reported previously) reported over 96% accuracy in the trials of its Sentinel monitoring system for Acute Kidney Injury in three Israeli Intensive Care Units. The devices will now be manufactured by Israel’s Elcam Medical, which has also invested $1.5 million in Serreno.

Ben Gurion University researchers have discovered that proteins called BMP5/7 are new promising potential therapeutics for Parkinson’s disease. In lab tests, the proteins prevented the accumulation of toxic alpha-synuclein clumps and loss of vital dopamine-producing brain cells.

Normal cells have 23 chromosomes from each parent. But cancer cells do not, and scientists have been trying for years to exploit that fact. Now Tel Aviv University scientists have deciphered the phenomena and can guide oncologists to the therapies most appropriate for each type of cancer.

Israel’s Breath of Health (BOH) has developed a breath test system that identifies Covid-19. Clinical trials at Israel’s Hadassah and Sheba Medical Centers have shown preliminary success rates of 98%.  BOH has signed an agreement with India's Reliance Group to distribute the system throughout India.